168 related articles for article (PubMed ID: 34849917)
1. Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
Kjeldsen S; Nielsen J; Mertz Nørgård B; Kjeldsen J
Inflamm Bowel Dis; 2022 Oct; 28(10):1513-1519. PubMed ID: 34849917
[TBL] [Abstract][Full Text] [Related]
2. Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.
Mahmud N; Weir DG; Kelleher D
Ir J Med Sci; 1999; 168(4):228-32. PubMed ID: 10624358
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.
Choi YI; Kim TJ; Park DK; Chung JW; Kim KO; Kwon KA; Kim YJ
Int J Colorectal Dis; 2019 Oct; 34(10):1713-1721. PubMed ID: 31471699
[TBL] [Abstract][Full Text] [Related]
4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
5. The Prevalence of Inflammatory Bowel Disease in Greenland.
Gantzel RH; Vesterdal JD; Haase AM; Petersen AJ; Grønbæk H; Pedersen ML
Inflamm Bowel Dis; 2023 Dec; 29(12):1879-1885. PubMed ID: 36702537
[TBL] [Abstract][Full Text] [Related]
6. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.
Xu F; Wheaton AG; Barbour KE; Liu Y; Greenlund KJ
Dig Dis Sci; 2021 Jun; 66(6):1818-1828. PubMed ID: 32700169
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
9. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data.
Attauabi M; Dahlerup JF; Poulsen A; Hansen MR; Vester-Andersen MK; Eraslan S; Prahm AP; Pedersen N; Larsen L; Jess T; Neumann A; Haderslev KV; Molazahi A; Lødrup AB; Glerup H; Oppfeldt AM; Jensen MD; Theede K; Kiszka-Kanowitz M; Seidelin JB; Burisch J
J Crohns Colitis; 2022 Jun; 16(5):757-767. PubMed ID: 34755858
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
Nørgård BM; Zegers FD; Nielsen J; Knudsen T; Kjeldsen J
Inflamm Bowel Dis; 2023 Sep; 29(9):1470-1476. PubMed ID: 37067508
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
Sinh P; Tabibian JH; Biyani PS; Mehta K; Mansoor E; Loftus EV; Dave M
Dig Dis Sci; 2021 Dec; 66(12):4169-4177. PubMed ID: 33492533
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis.
Mahmoud AA; Abdelhay A; Khamis A; Mostafa M; Shehadah A; Mohamed MS; Eltaher B; Malik T
Ann Hematol; 2023 Jul; 102(7):1705-1711. PubMed ID: 37093242
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in IBD: The experience of a single tertiary IBD center.
Rizzello F; Calabrese C; Salice M; Calandrini L; Privitera H; Melotti L; Peruzzi G; Dussias N; Belluzzi A; Scaioli E; Decorato A; Siniscalchi A; Filippone E; Laureti S; Rottoli M; Poggioli G; Gionchetti P
Dig Liver Dis; 2021 Mar; 53(3):271-276. PubMed ID: 33451910
[TBL] [Abstract][Full Text] [Related]
15. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis.
Lee MH; Li HJ; Wasuwanich P; Kim SE; Kim JY; Jeong GH; Park S; Yang JW; Kim MS; Yon DK; Lee SW; Koyanagi A; Jacob L; Kim EY; Cheon JH; Shin JI; Smith L
Rev Med Virol; 2023 Mar; 33(2):e2414. PubMed ID: 36504172
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
18. Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizens.
Krarup AL; Larsen L; Nayeb AB; Grøntved S; Paaske Johnsen S; Esbjørn M; Fallingborg J; Nielsen GL; Allin K; Jess T; Olesen AE
Scand J Gastroenterol; 2023 May; 58(5):477-482. PubMed ID: 36356318
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease in the elderly: A focus on disease characteristics and treatment patterns.
Mosli MH; Alghamdi MK; Bokhary OA; Alzahrani MA; Takieddin SZ; Galai TA; Alsahafi MA; Saadah OI
Saudi J Gastroenterol; 2023; 29(4):212-218. PubMed ID: 36722525
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
